“There’s a lot of rhetoric in the air, and most of it nonproductive,” Mr. Ricks told CNBC. “We could cap [drug prices] forever. And what we get is less innovation and still have growing healthcare costs.”
Instead of capping drug prices, Mr. Ricks told CNBC he supports the bill from Senate Finance Committee that would add an out-of-pocket maximum for Medicare beneficiaries.
“We agree it’s time for change,” Mr. Ricks said. “We agree that patients need relief in the cost of medications.”
Read the full report here.
More articles on pharmacy:
Pfizer to merge off-patent business with Mylan
Senate panel advances drug-pricing legislation
Clinics leaving family planning program may have to toss thousands of dollars worth of drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
